Fertility and Sterility
Volume 94, Issue 5 , Pages 1589-1594 , October 2010

A single midcycle dose of levonorgestrel similar to emergency contraceptive does not alter the expression of the L-selectin ligand or molecular markers of endometrial receptivity

  • Wilder Alberto Palomino, M.D.

      Affiliations

    • Instituto de Investigaciones Materno Infantil, Universidad de Chile, Santiago de Chile, Chile
    • Departamento de Obstetricia y Ginecologia, Hospital Clinico San Borja Arriarán, Facultad de Medicina, Universidad de Chile, Santiago de Chile, Chile
    • Corresponding Author InformationReprint requests: Wilder A. Palomino, M.D., Institute for Maternal and Child Research, IDIMI, University of Chile, Departamento de Obstetricia y Ginecologia, Hospital Clinico San Borja Arriarán, P.O Box: 226-3, Santiago de Chile, Chile (FAX: 56-2-4247240).
    • ,
  • Paulina Kohen, B.Sc.

      Affiliations

    • Instituto de Investigaciones Materno Infantil, Universidad de Chile, Santiago de Chile, Chile
    • ,
  • Luigi Devoto, M.D.

      Affiliations

    • Instituto de Investigaciones Materno Infantil, Universidad de Chile, Santiago de Chile, Chile
    • Departamento de Obstetricia y Ginecologia, Hospital Clinico San Borja Arriarán, Facultad de Medicina, Universidad de Chile, Santiago de Chile, Chile

Received 20 June 2009 ,Revised 8 September 2009 ,Accepted 10 September 2009.

References 

  1. Croxatto HB, Ortiz ME, Müller AL. Mechanisms of action of emergency contraception. Steroids. 2003;68:1095–1098
  2. Marions L, Hultenby K, Lindell I, Sun X, Ståbi B, Gemzell Danielsson K. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol. 2002;100:65–71
  3. Gemzell-Danielsson K, Marions L. Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception. Hum Reprod Update. 2004;10:341–348
  4. Durand M, Del Carmen Cravioto M, Raymond EG, Durán-Sánchez O, De Cruz-Hinojosa M, Castell-Rodríguez A, et al. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception. 2001;64:227–234
  5. Lessey BA, Yeh I, Castelbaum AJ, Fritz MA, Ilesanmi AO, Korzeniowski P, et al. Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation. Fertil Steril. 1996;65:477–483
  6. Devoto L, Fuentes A, Palomino A, Espinoza A, Kohen P, Ranta S, et al. Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route. Fertil Steril. 2005;84:46–51
  7. Kohen P, Castro O, Palomino A, Muñoz A, Christenson LK, Sierralta W, et al. The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase. J Clin Endocrinol Metab. 2003;88:3421–3430
  8. Palomino WA, Fuentes A, González RR, Gabler F, Boric MA, Vega M, et al. Differential expression of endometrial integrins and progesterone receptor during the window of implantation in normo-ovulatory women treated with clomiphene citrate. Fertil Steril. 2005;83:587–593
  9. Angelopoulou R, Balla M, Lavranos G, Chalikias M, Kitsos C, Bakad S, et al. Evaluation of immunohistochemical markers of germ cells' proliferation in the developing rat testis. Tissue Cell. 2008;40:43–50
  10. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril. 1950;1:3–25
  11. Guttinger A, Critchley HO. Endometrial effects of intrauterine levonorgestrel. Contraception. 2007;75:S93–S98
  12. Critchley HO, Bailey DA, Au CL, Affandi B, Rogers PA. Immunohistochemical sex steroid receptor distributions in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Hum Reprod. 1993;8:1632–1639
  13. Pekonen F, Nyman T, Lahteenmaki P, Haukkamaa M, Rutanen EM. Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium. J Clin Endocrinol Metab. 1992;75:660–664
  14. Milling Smith OP, Critchley HOD. Progestogen only contraception and endometrial break through bleeding. Angiogenesis. 2005;8:117–126
  15. Mote PA, Balleine RL, McGowan EM, Clarke CL. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab. 1999;84:2963–2971
  16. Igarashi TM, Bruner-Tran KL, Yeaman GR, Lessey BA, Edwards DP, Eisenberg E, et al. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil Steril. 2005;84:67–74
  17. Lessey BA. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids. 2003;68:809–815
  18. Genbacev OD, Prakobphol A, Foulk RA, Krtolica AR, Ilic D, Singer MS, et al. Trophoblast L-selectin mediated adhesion at the maternal-fetal interface. Science. 2003;299:405–408
  19. Donaghay M, Lessey BA. Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med. 2007;25:461–475
  20. González RR, Palomino A, Boric A, Vega M, Devoto L. A quantitative evaluation of α1, α4, α5 and αvβ3 endometrial integrins of fertile and unexplained infertile women during the menstrual cycle. A flow cytometric appraisal. Hum Reprod. 1999;14:2485–2492
  21. Stavreus-Evers A, Mandelin E, Koistinen R, Aghajanova L, Hovatta O, Seppälä M. Glycodelin is present in pinopodes of receptive-phase human endometrium and is associated with down-regulation of progesterone receptor B. Fertil Steril. 2006;85:1803–1811
  22. Mandelin E, Koistinen H, Koistinen R, Affandi B, Seppälä M. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin-A in endometrium during midcycle: another contraceptive mechanism?. Hum Reprod. 1997;12:2671–2675
  23. Durand M, Seppala M, Del Carmen Cravioto M, Koistinenc H, Koistinenb R, Gonzalez-Macedo J, et al. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle. Contraception. 2005;71:451–457
  24. Do Nascimento J, Seppala M, Perdigao A, Espejo-Arce X, Munuce MJ, Hautala L, et al. In vivo assessment of the human sperm acrosome reaction and the expression of glycodelin-A in human endometrium after levonorgestrel-emergency contraceptive pill administration. Hum Reprod. 2007;22:2190–2195
  25. Murray MJ, Meyer WR, Zaino RJ, Lessey BA, Novotny DB, Ireland K, et al. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril. 2004;81:1333–1343
  26. Meng CX, Andersson KL, Bentin-Ley U, Gemzell-Danielsson K, Lalitkumar PG. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model. Fertil Steril. 2009;91:256–264

 W.A.P. has nothing to disclose. P.K. has nothing to disclose. L.D. has nothing to disclose.

 Supported by the Chilean Research Council CONICYT–FONDAP Grant #150160000 and Programa latinoamericano de Investigacion en Salud Sexual y Reproductiva (PLISSER) Reentry-Grant #213-99, Mexico.

PII: S0015-0282(09)03692-9

doi: 10.1016/j.fertnstert.2009.09.013

Fertility and Sterility
Volume 94, Issue 5 , Pages 1589-1594 , October 2010

Article Tools

* Image Usage & Resolution